(BMRN) Biomarin Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biomarin Pharmaceutical | (BMRN) share price targets
Complete technical analysis of Biomarin Pharmaceutical (BMRN) by charts plus indicators, forecast predictions and share price targets for Biomarin Pharmaceutical (BMRN)
Biomarin Pharmaceutical trades in USA in Health Care sector.
10 day averaged volume of Biomarin Pharmaceutical is 2091050
| Date | Daily Closing Price | Open | High | Low | Volume |
| 21 Thu Aug 2025 | 58.07 | 57.48 | 58.68 | 57.44 | 0.673 times |
| 20 Wed Aug 2025 | 57.96 | 57.50 | 58.70 | 57.27 | 0.843 times |
| 19 Tue Aug 2025 | 57.31 | 57.80 | 58.14 | 57.16 | 0.686 times |
| 18 Mon Aug 2025 | 57.44 | 57.68 | 58.35 | 57.31 | 0.809 times |
| 15 Fri Aug 2025 | 57.54 | 58.27 | 59.09 | 57.19 | 1.208 times |
| 14 Thu Aug 2025 | 58.00 | 57.84 | 58.12 | 57.32 | 0.707 times |
| 13 Wed Aug 2025 | 58.30 | 56.94 | 58.62 | 56.94 | 1.285 times |
| 12 Tue Aug 2025 | 56.86 | 56.80 | 57.46 | 56.45 | 0.86 times |
| 11 Mon Aug 2025 | 56.80 | 56.92 | 57.63 | 56.48 | 0.913 times |
| 08 Fri Aug 2025 | 57.33 | 59.31 | 60.09 | 56.36 | 1.685 times |
My analysis of stock is bearish for shortterm, and stock might move down till 57.1 or till 55.6. Use a stoploss of 58.38 and if the stock hits stoploss, then it can shoot up till 59.62
Share price targets for Biomarin Pharmaceutical (BMRN)
| Target Type | Value |
| Downside Target | 52.93 |
| Downside Target | 56.36 |
| Upside Target | 58.59 |
| Upside Target | 59.09 |
| Upside Target | 59.62 |
| Upside Target | 60.43 |
| Upside Target | 63.97 |
| Upside Target | 65.40 |
| Upside Target | 70.63 |
Intraday share price targets for Biomarin Pharmaceutical (BMRN)
| Target Type | Value |
| Downside Intraday Target | 57.25 |
| Downside Intraday Target | 56.44 |
| Upside Intraday Target | 58.79 |
| Upside Intraday Target | 59.52 |
| Downside Intraday Target | 57.98 |
Weekly technical analysis of Biomarin Pharmaceutical (BMRN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 21 Thu Aug 2025 | 58.07 | 57.68 | 58.70 | 57.16 | 0.606 times |
| 15 Fri Aug 2025 | 57.54 | 56.92 | 59.09 | 56.45 | 0.702 times |
| 08 Fri Aug 2025 | 57.33 | 63.33 | 63.97 | 56.36 | 1.315 times |
| 01 Fri Aug 2025 | 58.14 | 59.13 | 59.62 | 56.52 | 1.535 times |
| 25 Fri Jul 2025 | 59.01 | 57.28 | 60.43 | 56.48 | 1.044 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biomarin Pharmaceutical (BMRN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 21 Thu Aug 2025 | 58.07 | 57.50 | 63.97 | 56.36 | 0.889 times |
| 31 Thu Jul 2025 | 57.85 | 54.64 | 60.43 | 54.63 | 0.938 times |
| 30 Mon Jun 2025 | 54.97 | 57.99 | 58.59 | 53.72 | 0.925 times |
| 30 Fri May 2025 | 58.07 | 63.20 | 65.40 | 57.11 | 1.271 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biomarin Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 57.56 and Biomarin Pharmaceutical (BMRN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biomarin Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 57.56 and Biomarin Pharmaceutical (BMRN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.